Literature DB >> 17482562

A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Judith A Hobert1, Glyn Dawson.   

Abstract

Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) results from a deficiency of CLN3, a protein recently identified within detergent-resistant membranes (DRMs). To study the function of CLN3 within these domains we isolated DRMs from control and JNCL-brain and noted that JNCL-derived DRMs are less buoyant than control. Analysis of DRM phospholipids derived from JNCL-brain revealed a reduction of bis(monoacylglycerol)phosphate. Metabolic labeling of JNCL-fibroblasts demonstrated a reduction in the synthesis of bis(monoacylglycerol)phosphate which was restored following complementation with wild-type-CLN3, substantiating our initial observation in brain. Metabolic labeling of cell lines overexpressing wild-type-CLN3 resulted in increased bis(monoacylglycerol)phosphate synthesis, while overexpression of mutant CLN3-L170P decreased bis(monoacylglycerol)phosphate synthesis. These data illustrate a new finding, a strong correlation between CLN3 protein expression and synthesis of bis(monoacylglycerol)phosphate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482562      PMCID: PMC2720048          DOI: 10.1016/j.bbrc.2007.04.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase.

Authors:  Srinivas B Narayan; Dinesh Rakheja; Lu Tan; Johanne V Pastor; Michael J Bennett
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

Review 2.  Approaches to DNA mutagenesis: an overview.

Authors:  M M Ling; B H Robinson
Journal:  Anal Biochem       Date:  1997-12-15       Impact factor: 3.365

3.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

4.  Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway.

Authors:  D A Wiesner; G Dawson
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

5.  Studies of membrane association of CLN3 protein.

Authors:  W Kaczmarski; K E Wisniewski; A Golabek; A Kaczmarski; E Kida; M Michalewski
Journal:  Mol Genet Metab       Date:  1999-04       Impact factor: 4.797

6.  A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.

Authors:  Yoojin Kim; Denia Ramirez-Montealegre; David A Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

7.  Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.

Authors: 
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

8.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.

Authors:  M Savukoski; T Klockars; V Holmberg; P Santavuori; E S Lander; L Peltonen
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

10.  Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells.

Authors:  W Spinelli; K H Sonnenfeld; D N Ishii
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

View more
  17 in total

1.  Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.

Authors:  Kristiina Uusi-Rauva; Aija Kyttälä; Rik van der Kant; Jouni Vesa; Kimmo Tanhuanpää; Jacques Neefjes; Vesa M Olkkonen; Anu Jalanko
Journal:  Cell Mol Life Sci       Date:  2012-01-20       Impact factor: 9.261

2.  Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

Authors:  Colleen S Stein; Paul H Yancey; Inês Martins; Rita D Sigmund; John B Stokes; Beverly L Davidson
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

Review 3.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

4.  Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.

Authors:  Zeynep Akgoc; Miguel Sena-Esteves; Douglas R Martin; Xianlin Han; Alessandra d'Azzo; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2015-03-20       Impact factor: 5.922

5.  A novel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3(-/-) cells.

Authors:  Amanda L Getty; Jared W Benedict; David A Pearce
Journal:  Exp Cell Res       Date:  2010-09-17       Impact factor: 3.905

6.  S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.

Authors:  Sandra Codlin; Sara E Mole
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

Review 7.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

8.  The fission yeast model for the lysosomal storage disorder Batten disease predicts disease severity caused by mutations in CLN3.

Authors:  Rebecca L Haines; Sandra Codlin; Sara E Mole
Journal:  Dis Model Mech       Date:  2008-12-22       Impact factor: 5.758

9.  Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.

Authors:  N S Osório; B Sampaio-Marques; C-H Chan; P Oliveira; D A Pearce; N Sousa; F Rodrigues
Journal:  Genes Brain Behav       Date:  2009-02-19       Impact factor: 3.449

10.  CLN3 loss disturbs membrane microdomain properties and protein transport in brain endothelial cells.

Authors:  Luis Tecedor; Colleen S Stein; Mark L Schultz; Hany Farwanah; Konrad Sandhoff; Beverly L Davidson
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.